Delivery Order SPE2DR25D9239-SPE2DR26FFBY8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $49,058.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 ml vials. This firm fixed-price delivery order, awarded on January 22, 2026, with an ultimate completion date of February 12, 2026, was issued without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,905.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 ml vials. The delivery order, issued on January 16, 2026, with an ultimate completion date of February 9, 2026, operates under a firm fixed-price arrangement with no set-aside designation. This award is issued under DMS Pharmaceutical Group's Indefinite Delivery...
- The Defense Logistics Agency issued a delivery order valued at $4,905.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 ml vials. The delivery order, issued on January 2, 2026, with an ultimate completion date of January 26, 2026, operates under a firm fixed-price contract structure with no set-aside designation. This award falls under DMS Pharmaceutical Group's Pharmaceutical Prime...
- The Defense Logistics Agency awarded a $58,869.72 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 ml vials. The delivery order was issued on January 12, 2026, with an ultimate completion date of February 3, 2026, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $139,529.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta (420 mg/14 mL vials). The delivery order, issued on November 20, 2025, with an ultimate completion date of December 12, 2025, carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $77,830.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 ml vials. The delivery order was issued on October 20, 2025, with an ultimate completion date of November 10, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $19,623.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 mL vials. This firm fixed-price delivery order, issued on January 14, 2026, with an ultimate completion date of February 5, 2026, carries no set-aside designation, indicating the award was made through unrestricted competition. The product will be delivered to Park...
- The Defense Logistics Agency awarded a delivery order valued at $9,301.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta (pertuzumab) 420 mg/14 mL vials. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, was awarded without set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a $41,441.33 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 mL vials. This firm fixed-price delivery order, issued on November 7, 2025, with an ultimate completion date of December 2, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency awarded a delivery order valued at $4,650.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 mL vials. The contract, issued on December 17, 2025, with an ultimate completion date of January 9, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract...
- SPE2DR25D9239Indefinite Delivery Contract
- SPE2DR25D9239-SPE2DR26FFBY8Delivery Order
The Defense Logistics Agency issued a delivery order valued at approximately $29.4K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta 420 mg/14 mL vials. This firm fixed-price delivery order, awarded on January 22, 2026, represents performance through February 12, 2026, and carries no set-aside designation, indicating the awardee competed in unrestricted federal procurement. DMS Pharmaceutical Group was selected as the prime contractor with no identified subcontractor relationships on this award. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded in November 2025 with a $499.9 billion ceiling value through December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic drugs, biologics, and medical consumables. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.4k | 1/21/26 |